Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH (DIM)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
09/18/2018 09/19/2018 09/20/2018 09/21/2018 09/24/2018 Date
112.5(c) 113.3(c) 112(c) 113.6(c) 113.3 Last
75 183 49 863 67 024 439 397 13 902 Volume
+1.72% +0.71% -1.15% +1.43% -0.26% Change
More quotes
Financials (EUR)
Sales 2018 1 201 M
EBIT 2018 272 M
Net income 2018 195 M
Debt 2018 127 M
Yield 2018 0,46%
Sales 2019 1 339 M
EBIT 2019 316 M
Net income 2019 228 M
Debt 2019 62,6 M
Yield 2019 0,53%
P/E ratio 2018 53,89
P/E ratio 2019 46,11
EV / Sales2018 8,82x
EV / Sales2019 7,87x
Capitalization 10 472 M
More Financials
Company
Sartorius Stedim Biotech SA manufactures and supplies biopharmaceutical products and medical equipment.It offers laboratory equipment for cell cultivation, weighing, water purification, liquid handling and filtration.The company services include customer support, laboratory training courses, and... 
More about the company
Surperformance© ratings of Sartorius Stedim Biotech
Trading Rating : Investor Rating :
More Ratings
Latest news on SARTORIUS STEDIM BIOTECH
09/15SARTORIUS STEDIM BIOTECH : and Repligen collaborate on perfusion-enabled bioreac..
AQ
09/13SARTORIUS STEDIM BIOTECH : Findings from Sartorius Stedim Biotech Update Knowled..
AQ
09/06SARTORIUS STEDIM BIOTECH : and Repligen collaborate to create novel perfusion-en..
AQ
09/06SARTORIUS STEDIM BIOTECH : and Repligen collaborate on perfusion enabled bioreac..
AQ
09/06SARTORIUS STEDIM BIOTECH : Collaboration will see introduction of next-generatio..
AQ
09/05SARTORIUS STEDIM BIOTECH : and Repligen Corporation Partner to Introduce Next-Ge..
AQ
07/24SARTORIUS STEDIM BIOTECH SA : Information on Document Availability
EQ
07/11SARTORIUS STEDIM BIOTECH : and Penn State partner to advance teaching, research ..
AQ
07/02SARTORIUS STEDIM BIOTECH SA : Half-year report of the liquidity contract with th..
EQ
06/14SARTORIUS STEDIM BIOTECH : And Siemens Sign Long-Term Cooperation Agreement In T..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/21Disruption to medical business takes toll on Smiths Group
RE
09/21MAZOR ROBOTICS : Medtronic to acquire Mazor in $1.64 billion deal
RE
09/21MEDTRONIC : to Acquire Mazor Robotics for $1.64 Billion
DJ
09/13Smiths and ICU Medical healthcare merger talks collapse
RE
09/11STRYKER : to Buy Invuity for About $190 Million
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
MarketScreener Strategies on SARTORIUS STEDIM BIOTECH 
SARTORIUS STEDIM BIO - 2017
A reversal of the trend is being expected
SELL
SARTORIUS STEDIM BIO - 2017
Expect the comeback of a strong trend
BUY
More Strategies
Latest Tweets
09/05Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-G.. 
09/04$RGEN Repligen Corporation Press Release: Sartorius Stedim Biotech and Replig.. 
09/04Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND.. 
08/27Jacob Sartorius at Magic Springs Sept. 1  
08/01Millie Bobby Brown and Jacob Sartorius split: ‘We are both happy’  
More tweets
Qtime:57
News from SeekingAlpha
07/25Sartorius Stedim Biotech 2018 Q2 - Results - Earnings Call Slides 
07/24Sartorius Stedim Biotech reports 1H results 
04/24Sartorius Stedim Biotech reports Q1 results 
02/22Sartorius Stedim Biotech (SDMHF) Investor Presentation - Slideshow 
01/31Sartorius Stedim Biotech 2017 Q4 - Results - Earnings Call Slides 
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 91,2 €
Spread / Average Target -20%
EPS Revisions
Managers
NameTitle
Joachim Kreuzburg Chairman, CEO, CFO & Head-Human Resources
Volker Niebel Executive VP-Operations & Information Technology
Oscar-Werner Reif Executive VP-Research & Development
Liliane de Lassus Independent Non-Executive Director
Bernard Lemaître Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS STEDIM BIOTECH88.42%12 301
MEDTRONIC PLC21.18%132 148
BAXTER INTERNATIONAL19.69%41 336
ALIGN TECHNOLOGY71.40%30 589
ZIMMER BIOMET HOLDINGS8.92%26 744
TERUMO CORP24.35%22 561